Panagora Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $846K | Hold |
88,876
| – | – | ﹤0.01% | 748 |
|
|
2025
Q4 | $693K | Sell |
88,876
-34,990
| -28% | -$253K | ﹤0.01% | 801 |
|
|
2025
Q3 | $940K | Sell |
123,866
-270,168
| -69% | -$2.25M | ﹤0.01% | 674 |
|
|
2025
Q2 | $3.53M | Sell |
394,034
-135,536
| -26% | -$1.26M | 0.02% | 372 |
|
|
2025
Q1 | $3.97M | Sell |
529,570
-306,402
| -37% | -$2.47M | 0.02% | 372 |
|
|
2024
Q4 | $6.29M | Buy |
835,972
+159,680
| +24% | +$1.21M | 0.03% | 306 |
|
|
2024
Q3 | $5.14M | Buy |
676,292
+25,974
| +4% | +$197K | 0.02% | 345 |
|
|
2024
Q2 | $4.02M | Buy |
650,318
+17,759
| +3% | +$98K | 0.02% | 360 |
|
|
2024
Q1 | $3.21M | Sell |
632,559
-36,508
| -5% | -$205K | 0.02% | 436 |
|
|
2023
Q4 | $4.01M | Sell |
669,067
-58,413
| -8% | -$338K | 0.02% | 362 |
|
|
2023
Q3 | $5.15M | Buy |
727,480
+41,971
| +6% | +$302K | 0.03% | 289 |
|
|
2023
Q2 | $4.83M | Sell |
685,509
-6,374
| -0.9% | -$51.1K | 0.03% | 338 |
|
|
2023
Q1 | $5.77M | Sell |
691,883
-3,718
| -0.5% | -$35.8K | 0.04% | 342 |
|
|
2022
Q4 | $7.99M | Buy |
695,601
+193,020
| +38% | +$2.41M | 0.05% | 293 |
|
|
2022
Q3 | $6.33M | Buy |
502,581
+116,879
| +30% | +$1.5M | 0.04% | 312 |
|
|
2022
Q2 | $4.08M | Sell |
385,702
-6,306
| -2% | -$65K | 0.03% | 436 |
|
|
2022
Q1 | $6.37M | Buy |
392,008
+64,476
| +20% | +$1.03M | 0.03% | 359 |
|
|
2021
Q4 | $4.54M | Buy |
327,532
+104,126
| +47% | +$1.38M | 0.02% | 424 |
|
|
2021
Q3 | $3.21M | Buy |
223,406
+220,496
| +7,577% | +$3.48M | 0.02% | 542 |
|
|
2021
Q2 | $46K | Buy |
2,910
+2,425
| +500% | +$32.9K | ﹤0.01% | 2078 |
|
|
2021
Q1 | $5K | Buy |
485
+150
| +45% | +$1.55K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $2K | Buy |
+335
| New | +$1.73K | ﹤0.01% | 2605 |
|
|
2017
Q2 | – | Sell |
-27,165
| Closed | -$228K | – | 2595 |
|
|
2017
Q1 | $228K | Sell |
27,165
-4,312
| -14% | -$30K | ﹤0.01% | 1612 |
|
|
2016
Q4 | $199K | Hold |
31,477
| – | – | ﹤0.01% | 1752 |
|
|
2016
Q3 | $139K | Buy |
31,477
+4,312
| +16% | +$17.2K | ﹤0.01% | 1880 |
|
|
2016
Q2 | $77K | Buy |
+27,165
| New | +$84.3K | ﹤0.01% | 1975 |
|
|
2016
Q1 | – | Sell |
-8,393
| Closed | -$87K | – | 2295 |
|
|
2015
Q4 | $87K | Buy |
8,393
+4,398
| +110% | +$43.7K | ﹤0.01% | 1831 |
|
|
2015
Q3 | $46K | Sell |
3,995
-1,713
| -30% | -$22.9K | ﹤0.01% | 2008 |
|
|
2015
Q2 | $85K | Buy |
+5,708
| New | +$64.9K | ﹤0.01% | 1999 |
|
|
2014
Q2 | – | Sell |
-246,190
| Closed | -$2.6M | – | 2326 |
|
|
2014
Q1 | $2.6M | Buy |
+246,190
| New | +$2.62M | 0.01% | 764 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC